- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
NanoInk, Inc., a Skokie-based company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries, announced today that it has reached a distribution agreement with Schmidt Scientific of Taiwan and China. Under the terms of the agreement, Schmidt Scientific will assume the responsibility as exclusive distributor for NanoInk's NSCRIPTOR® Dip Pen Nanolithography® (DPN) System in China, Taiwan, Hong Kong and Macao.
NanoInk's NSCRIPTOR DPN System is a fully integrated hardware and software system optimized for the DPN process of writing stable nanoscale patterns of molecular "ink" onto a sample substrate via a coated stylus tip. DPN users can build at resolutions ranging from many micrometers down to 15 nanometers, using virtually any material. This combination of ultrahigh resolution and material flexibility makes for numerous commercial applications.
"Schmidt Scientific's visibility and presence in the Nanotechnology markets in China and Taiwan will accelerate the adoption of our DPN technology in Asia," said Tom Levesque, Senior Director of DPN Global Sales. "Our technology is already in use at several prominent universities in the region, and we see it migrating into industrial development as a general purpose nanofabrication tool with a low cost and a small desktop footprint."
Bruce Lu, President of Schmidt Scientific Taiwan, Ltd., stated, "This is an important milestone in the continuing growth and success of our company. We look forward to NanoInk becoming a cornerstone of the products Schmidt Scientific offers to our nanotechnology customers in China and Taiwan."
More than thirty-five international research institutions including Academia Sinica in Taiwan, Central Electronics Engineering Research Institute (CEERI) in India, Northwestern University, Stanford University, and the University of California at Santa Barbara have already selected the NSCRIPTOR DPN System as one of the best methods to create nanoscale structures from a wide variety of materials.
About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. With DPN®, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and also its high-resolution Nanoencryption™ technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 100 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, and the University of Illinois at Urbana-Champaign and the Georgia Institute of Technology.
About Schmidt Scientific Sales
Schmidt Scientific is an established trading company in Taiwan and China with over 130 employees serving medical, instrumentation and nanotechnology markets.
For more information about Schmidt Scientific Taiwan, see http://www.schmidt.com.tw and for Schmidt International Trading in China see http://www.schmidts.com.cn .
For more information, please click here
Dresner Corporate Services for NanoInk
Dresner Corporate Services for NanoInk
Copyright © Market WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Soft decoupling of organic molecules on metal June 23rd, 2016
Radiation-guided nanoparticles zero in on metastatic cancer July 1st, 2016
FEI and University of Liverpool Announce QEMSCAN Research Initiative: University of Liverpool will utilize FEI’s QEMSCAN technology to gain a better insight into oil and gas reserves & potentially change the approach to evaluating them June 22nd, 2016
French Research Team Helps Extend MRI Detection of Diseases & Lower Health-Care Costs: CEA, INSERM and G2ELab Brings Grenoble Region’s Expertise In Advanced Medicine & Magnetism Applications to H2020 IDentIFY Project June 21st, 2016